0 XP   0   0   0

Heidelberg Pharma AG










Financial Health of Heidelberg Pharma AG




Comparing to competitors in the industry




  Industry Rankings  


Heidelberg Pharma AG
Buy, Hold or Sell?

Should you buy, hold or sell Heidelberg Pharma AG?

I guess you are interested in Heidelberg Pharma AG. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Heidelberg Pharma AG

Let's start. I'm going to help you getting a better view of Heidelberg Pharma AG. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Heidelberg Pharma AG even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Heidelberg Pharma AG is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Heidelberg Pharma AG. The closing price on 2022-11-25 was €5.72 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Heidelberg Pharma AG Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Heidelberg Pharma AG.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Heidelberg Pharma AG earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Heidelberg Pharma AG to the  industry mean.
  • A Net Profit Margin of -122.9% means that €-1.23 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Heidelberg Pharma AG:

  • The MRQ is -122.9%. The company is making a huge loss. -2
  • The TTM is -578.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-122.9%TTM-578.7%+455.8%
TTM-578.7%YOY-1,875.3%+1,296.6%
TTM-578.7%5Y-838.0%+259.3%
5Y-838.0%10Y-838.0%0.0%
1.1.2. Return on Assets

Shows how efficient Heidelberg Pharma AG is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Heidelberg Pharma AG to the  industry mean.
  • -15.5% Return on Assets means that Heidelberg Pharma AG generated €-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Heidelberg Pharma AG:

  • The MRQ is -15.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -22.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.5%TTM-22.0%+6.5%
TTM-22.0%YOY-20.2%-1.8%
TTM-22.0%5Y-21.7%-0.4%
5Y-21.7%10Y-21.7%0.0%
1.1.3. Return on Equity

Shows how efficient Heidelberg Pharma AG is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Heidelberg Pharma AG to the  industry mean.
  • 0.0% Return on Equity means Heidelberg Pharma AG generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Heidelberg Pharma AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-27.2%+27.2%
TTM-27.2%YOY-41.9%+14.7%
TTM-27.2%5Y-30.1%+2.9%
5Y-30.1%10Y-30.1%0.0%

1.2. Operating Efficiency of Heidelberg Pharma AG.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Heidelberg Pharma AG is operating .

  • Measures how much profit Heidelberg Pharma AG makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Heidelberg Pharma AG to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Heidelberg Pharma AG:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Heidelberg Pharma AG is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 2.87 means that the operating costs are €2.87 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Heidelberg Pharma AG:

  • The MRQ is 2.870. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.708. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.870TTM7.708-4.838
TTM7.708YOY23.373-15.665
TTM7.7085Y10.841-3.133
5Y10.84110Y10.8410.000

1.3. Liquidity of Heidelberg Pharma AG.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Heidelberg Pharma AG is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 0.59 means the company has €0.59 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Heidelberg Pharma AG:

  • The MRQ is 0.587. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.585. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.587TTM0.585+0.002
TTM0.585YOY1.081-0.496
TTM0.5855Y0.684-0.099
5Y0.68410Y0.6840.000
1.3.2. Quick Ratio

Measures if Heidelberg Pharma AG is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Heidelberg Pharma AG to the  industry mean.
  • A Quick Ratio of 0.06 means the company can pay off €0.06 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Heidelberg Pharma AG:

  • The MRQ is 0.055. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.052. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.055TTM0.052+0.003
TTM0.052YOY0.056-0.004
TTM0.0525Y0.053-0.001
5Y0.05310Y0.0530.000

1.4. Solvency of Heidelberg Pharma AG.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Heidelberg Pharma AG assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Heidelberg Pharma AG to industry mean.
  • A Debt to Asset Ratio of 1.20 means that Heidelberg Pharma AG assets are financed with 120.4% credit (debt) and the remaining percentage (100% - 120.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Heidelberg Pharma AG:

  • The MRQ is 1.204. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.990. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.204TTM0.990+0.214
TTM0.990YOY0.518+0.471
TTM0.9905Y0.896+0.094
5Y0.89610Y0.8960.000
1.4.2. Debt to Equity Ratio

Measures if Heidelberg Pharma AG is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Heidelberg Pharma AG to the  industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Heidelberg Pharma AG:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.561-0.561
TTM0.561YOY1.077-0.515
TTM0.5615Y0.664-0.103
5Y0.66410Y0.6640.000

2. Market Valuation of Heidelberg Pharma AG

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Heidelberg Pharma AG generates.

  • Above 15 is considered overpriced but always compare Heidelberg Pharma AG to the  industry mean.
  • A PE ratio of -40.83 means the investor is paying €-40.83 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Heidelberg Pharma AG:

  • The EOD is -42.314. Company is losing money. -2
  • The MRQ is -40.834. Company is losing money. -2
  • The TTM is -53.737. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-42.314MRQ-40.834-1.480
MRQ-40.834TTM-53.737+12.903
TTM-53.737YOY-39.971-13.767
TTM-53.7375Y-50.984-2.753
5Y-50.98410Y-50.9840.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Heidelberg Pharma AG.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Heidelberg Pharma AG:

  • The MRQ is 57.837. Seems overpriced? -1
  • The TTM is -1,275.481. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ57.837TTM-1,275.481+1,333.318
TTM-1,275.4815Y-1,275.4810.000
5Y-1,275.48110Y-1,275.4810.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Heidelberg Pharma AG is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of -31.06 means the investor is paying €-31.06 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Heidelberg Pharma AG:

  • The EOD is -32.188. Bad. Book ratio is negative. -2
  • The MRQ is -31.062. Bad. Book ratio is negative. -2
  • The TTM is -174.117. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-32.188MRQ-31.062-1.125
MRQ-31.062TTM-174.117+143.055
TTM-174.117YOY16.754-190.872
TTM-174.1175Y-135.943-38.174
5Y-135.94310Y-135.9430.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Heidelberg Pharma AG compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.132-0.145+10%0.402-133%-0.036-73%-0.036-73%
Book Value Growth---0.730-5.685+679%---5.685+679%-5.685+679%
Book Value Per Share---0.178-0.010-95%0.402-144%0.073-344%0.073-344%
Book Value Per Share Growth---0.741-5.483+640%---5.483+640%-5.483+640%
Current Ratio--0.5870.585+0%1.081-46%0.684-14%0.684-14%
Debt To Asset Ratio--1.2040.990+22%0.518+132%0.896+34%0.896+34%
Debt To Equity Ratio---0.561-100%1.077-100%0.664-100%0.664-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.135-0.150+11%-0.169+25%-0.154+14%-0.154+14%
Eps Growth---0.7060.856-182%--0.856-182%0.856-182%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---1.229-5.787+371%-18.753+1426%-8.380+582%-8.380+582%
Operating Margin----0%-0%-0%-0%
Operating Ratio--2.8707.708-63%23.373-88%10.841-74%10.841-74%
Pb Ratio-32.188-4%-31.062-174.117+461%16.754-285%-135.943+338%-135.943+338%
Pe Ratio-42.314-4%-40.834-53.737+32%-39.971-2%-50.984+25%-50.984+25%
Peg Ratio--57.837-1275.481+2305%---1275.481+2305%-1275.481+2305%
Price Per Share5.720+3%5.5205.425+2%6.740-18%5.688-3%5.688-3%
Price To Total Gains Ratio-43.463-4%-41.943-58.073+38%16.754-350%-43.108+3%-43.108+3%
Profit Growth---69.41293.165-175%--93.165-175%93.165-175%
Quick Ratio--0.0550.052+5%0.056-1%0.053+4%0.053+4%
Return On Assets---0.155-0.220+42%-0.202+30%-0.217+40%-0.217+40%
Return On Equity----0.2720%-0.4190%-0.3010%-0.3010%
Revenue Growth---2.105-0.148-93%---0.148-93%-0.148-93%
Total Gains Per Share---0.132-0.145+10%0.402-133%-0.036-73%-0.036-73%
Total Gains Per Share Growth---0.7310.288-354%--0.288-354%0.288-354%
Usd Book Value---6319307.149-342013.130-95%14304218.604-144%2587233.216-344%2587233.216-344%
Usd Book Value Change Per Share---0.137-0.151+10%0.419-133%-0.037-73%-0.037-73%
Usd Book Value Per Share---0.185-0.010-95%0.419-144%0.076-344%0.076-344%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.141-0.156+11%-0.175+25%-0.160+14%-0.160+14%
Usd Price Per Share5.952+3%5.7445.645+2%7.013-18%5.918-3%5.918-3%
Usd Profit---4807014.274-5335616.628+11%-5995764.714+25%-5467646.245+14%-5467646.245+14%
Usd Revenue--3912312.2564244955.163-8%319721.719+1124%3459908.474+13%3459908.474+13%
Usd Total Gains Per Share---0.137-0.151+10%0.419-133%-0.037-73%-0.037-73%
 EOD+3 -2MRQTTM+17 -13YOY+11 -125Y+13 -1710Y+13 -17

3.2. Fundamental Score

Let's check the fundamental score of Heidelberg Pharma AG based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-42.314
Price to Book Ratio (EOD)Between0-1-32.188
Net Profit Margin (MRQ)Greater than0-1.229
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.055
Current Ratio (MRQ)Greater than10.587
Debt to Asset Ratio (MRQ)Less than11.204
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.155
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Heidelberg Pharma AG based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.220
Ma 20Greater thanMa 505.635
Ma 50Greater thanMa 1005.158
Ma 100Greater thanMa 2005.270
OpenGreater thanClose5.740
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-08-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets29,805
Total Liabilities35,878
Total Stockholder Equity-6,073
 As reported
Total Liabilities 35,878
Total Stockholder Equity+ -6,073
Total Assets = 29,805

Assets

Total Assets29,805
Total Current Assets17,267
Long-term Assets17,267
Total Current Assets
Cash And Cash Equivalents 10,523
Net Receivables 1,618
Inventory 4,231
Total Current Assets  (as reported)17,267
Total Current Assets  (calculated)16,372
+/- 896
Long-term Assets
Goodwill 6,111
Intangible Assets 2,843
Long-term Assets Other 35
Long-term Assets  (as reported)12,537
Long-term Assets  (calculated)8,989
+/- 3,548

Liabilities & Shareholders' Equity

Total Current Liabilities29,401
Long-term Liabilities6,477
Total Stockholder Equity-6,073
Total Current Liabilities
Accounts payable 4,606
Other Current Liabilities 4,175
Total Current Liabilities  (as reported)29,401
Total Current Liabilities  (calculated)8,781
+/- 20,620
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt188
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)6,477
Long-term Liabilities  (calculated)188
+/- 6,289
Total Stockholder Equity
Total Stockholder Equity (as reported)-6,073
Total Stockholder Equity (calculated)0
+/- 6,073
Other
Capital Stock34,176
Common Stock Shares Outstanding 34,176
Net Invested Capital -6,073
Net Working Capital -12,134



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-08-312022-05-312022-02-282021-11-302021-08-31
> Total Assets 
28,547
21,732
20,652
33,937
29,805
29,80533,93720,65221,73228,547
   > Total Current Assets 
15,859
9,013
8,041
21,439
17,267
17,26721,4398,0419,01315,859
       Cash And Cash Equivalents 
13,598
6,141
4,515
18,017
10,523
10,52318,0174,5156,14113,598
       Net Receivables 
820
1,020
1,005
1,068
1,618
1,6181,0681,0051,020820
       Inventory 
807
746
1,277
1,058
4,231
4,2311,0581,277746807
   > Long-term Assets 
12,688
12,719
12,611
12,498
12,537
12,53712,49812,61112,71912,688
       Goodwill 
6,111
6,111
6,111
6,111
6,111
6,1116,1116,1116,1116,111
       Intangible Assets 
2,911
2,901
2,887
2,864
2,843
2,8432,8642,8872,9012,911
       Long-term Assets Other 
45
13
35
35
35
3535351345
> Total Liabilities 
14,799
15,033
21,016
35,513
35,878
35,87835,51321,01615,03314,799
   > Total Current Liabilities 
14,672
14,935
20,961
27,995
29,401
29,40127,99520,96114,93514,672
       Short Long Term Debt 
0
10,465
0
4,364
0
04,364010,4650
       Accounts payable 
1,108
903
1,237
2,585
4,606
4,6062,5851,2379031,108
       Other Current Liabilities 
2,592
0
3,830
15,336
4,175
4,17515,3363,83002,592
   > Long-term Liabilities 
128
98
55
7,518
6,477
6,4777,5185598128
       Capital Lease Obligations Min Short Term Debt
128
167
144
144
188
188144144167128
       Long-term Liabilities Other 
0
-1
0
0
0
000-10
> Total Stockholder Equity
13,747
6,699
-365
-1,576
-6,073
-6,073-1,576-3656,69913,747
   Common Stock00000
   Retained Earnings Total Equity00000
   Accumulated Other Comprehensive Income 00000
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 00000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-11-30)

Gross Profit (+$)
totalRevenue1,750
Cost of Revenue-4,712
Gross Profit-2,962-2,962
 
Operating Income (+$)
Gross Profit-2,962
Operating Expense-27,661
Operating Income-25,911-30,623
 
Operating Expense (+$)
Research Development18,750
Selling General Administrative3,986
Selling And Marketing Expenses-
Operating Expense27,66122,736
 
Net Interest Income (+$)
Interest Income0
Interest Expense-494
Net Interest Income-494-494
 
Pretax Income (+$)
Operating Income-25,911
Net Interest Income-494
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-26,139-25,911
EBIT - interestExpense = -494
-26,139
-25,644
Interest Expense494
Earnings Before Interest and Taxes (ebit)--25,644
Earnings Before Interest and Taxes (ebitda)-24,841
 
After tax Income (+$)
Income Before Tax-26,139
Tax Provision-0
Net Income From Continuing Ops-26,139-26,139
Net Income-26,139
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-494
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
GBPTWD.FOREX
37 minutes ago

I found you a Golden Cross on the daily chart of GBPTWD.FOREX.

GBPTWD.FOREX Daily Candlestick Chart
MYRCNH.FOREX
37 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MYRCNH.FOREX.

MYRCNH.FOREX Daily Candlestick Chart
CNHTHB.FOREX
38 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CNHTHB.FOREX.

CNHTHB.FOREX Daily Candlestick Chart
AEDNZD.FOREX
38 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AEDNZD.FOREX.

AEDNZD.FOREX Daily Candlestick Chart
EURCAD.FOREX
41 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EURCAD.FOREX.

EURCAD.FOREX Daily Candlestick Chart
DKKPKR.FOREX
42 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DKKPKR.FOREX.

DKKPKR.FOREX Daily Candlestick Chart
CEY.NASDAQ
52 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CEY.NASDAQ.

CEY.NASDAQ Daily Candlestick Chart
QINT.NYSE ARC
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of QINT.NYSE ARC.

QINT.NYSE ARC Daily Candlestick Chart
BNKU.NYSE ARC
53 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of BNKU.NYSE ARC.

BNKU.NYSE ARC Daily Candlestick Chart
BNKD.NYSE ARC
53 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of BNKD.NYSE ARC.

BNKD.NYSE ARC Daily Candlestick Chart
BBJP.BATS
53 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BBJP.BATS.

BBJP.BATS Daily Candlestick Chart
SIXH.NYSE ARC
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SIXH.NYSE ARC.

SIXH.NYSE ARC Daily Candlestick Chart
OVF.NYSE ARC
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of OVF.NYSE ARC.

OVF.NYSE ARC Daily Candlestick Chart
LCTD.NYSE ARC
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LCTD.NYSE ARC.

LCTD.NYSE ARC Daily Candlestick Chart
KHYB.NYSE ARC
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KHYB.NYSE ARC.

KHYB.NYSE ARC Daily Candlestick Chart
KNG.BATS
56 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of KNG.BATS.

KNG.BATS Daily Candlestick Chart
BPS-PU.TO
56 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BPS-PU.TO.

BPS-PU.TO Daily Candlestick Chart
AVDV.NYSE ARC
57 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AVDV.NYSE ARC.

AVDV.NYSE ARC Daily Candlestick Chart
AVDE.NYSE ARC
57 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AVDE.NYSE ARC.

AVDE.NYSE ARC Daily Candlestick Chart
ESALY.PINK
57 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ESALY.PINK.

ESALY.PINK Daily Candlestick Chart
ENGIY.PINK
57 minutes ago

I found you a Golden Cross on the daily chart of ENGIY.PINK.

ENGIY.PINK Daily Candlestick Chart
WDIV.NYSE ARC
59 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of WDIV.NYSE ARC.

WDIV.NYSE ARC Daily Candlestick Chart
VYMI.NASDAQ
59 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VYMI.NASDAQ.

VYMI.NASDAQ Daily Candlestick Chart
VTV.NYSE ARC
59 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VTV.NYSE ARC.

VTV.NYSE ARC Daily Candlestick Chart
VIGI.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VIGI.NASDAQ.

VIGI.NASDAQ Daily Candlestick Chart